PedAM

Pediatric Disease Annotations & Medicines

Disease	hepatitis c
Phenotype	C0039730\|thalassemia
Sentences	12
PubMedID- 23745128	In 2007, the prevalence of hepatitis c infection in patients with thalassemia in iran was reported 15.7% to 63.8% (9); while it was 32% among patients with thalassemia in jordan in 2009 (10).
PubMedID- 25653968	Conclusion: the results of this study indicate that using 30 mg/day elemental zinc did not significantly improve the outcome of treatment in thalassemia patients with chronic hepatitis c.
PubMedID- 24282420	The prevalence of chronic hepatitis c infection in patients with beta thalassemia major is 18%, particularly because of blood transfusion before hcv serological testing (1, 5).
PubMedID- 24130600	The present study was conducted on hepatitis c patients (either with beta thalassemia major or without beta thalassemia major).
PubMedID- 23082485	Hepcidin levels and iron status in beta-thalassemia major patients with hepatitis c virus infection.
PubMedID- 22500658	The incidence of hepatitis c in patients with thalassemia after screening in blood transfusion centers: a fourteen-year study.
PubMedID- 23414443	Natural history of hepatitis c in thalassemia major: a long-term prospective study.
PubMedID- 23489382	Transient elastography in hepatitis c virus-infected patients with beta-thalassemia for assessment of fibrosis.
PubMedID- 21845061	Effect of hepatic iron concentration and viral factors in chronic hepatitis c-infected patients with thalassemia major, treated with interferon and ribavirin.
PubMedID- 23412560	hepatitis c in patients with beta-thalassemia major.
PubMedID- 23293194	Conclusion: young beta thalassemia patients with active hepatitis c infection may have hepatic cirrhosis or fibrosis at young age when accompanied with hepatic siderosis.
PubMedID- 22180419	Il28b polymorphisms influence stage of fibrosis and spontaneous or interferon-induced viral clearance in thalassemia patients with hepatitis c virus infection.

Page: 1